STRUCTURAL CHARACTERIZATION OF TOXIN-BINDING GANGLIOSIDES BY TLC/VC-FTMS
STRUCTURAL CHARACTERIZATION OF TOXIN-BINDING GANGLIOSIDES BY TLC/VC-FTMS
批准号:
8365529
负责人:
WAYNE I LENCER
金额:
$0.38万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-06-01 至 2012-08-09
关键词:
AffectBindingBiologicalBiological ProcessBiologyCell LineCellsCeramidesCholesterolComplexCoupledCouplingDetectionElectrospray IonizationEndocytosisEpithelial CellsFatty AcidsFundingGD1a gangliosideGangliosidesGlycosphingolipidsGrantHigh Pressure Liquid ChromatographyHumanHydroxylationIntestinesKidneyLabelLengthLipidsMass Spectrum AnalysisMedicineMembraneMembrane MicrodomainsMethodsMonkeysNational Center for Research ResourcesOligosaccharidesPolysaccharidesPrincipal InvestigatorProteinsPulsarReportingResearchResearch InfrastructureResolutionResourcesRoleSamplingSorting - Cell MovementSourceSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationSpeedStructureSurfaceTimeToxinUnited States National Institutes of HealthVariantVero Cellsbasecholeragen receptorcostflotillinganglioside receptorpreventresearch studytrafficking
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
Glycosphingolipids and gangliosides participate in diverse biological processes, and their biological roles are dependent on the structures of both the oligosaccharide and the ceramide portions. We have used vibrationally cooled (VC)MALDI-FTMS for the detection of labile species followed by their efficient fragmentation by SORI-CAD and IRMPD. GM1 and GD1a gangliosides serve as trafficking receptors for cholera toxin and the related LTIIb toxin, respectively. We assume that GD1a ganglioside of human intestinal cells is not associated with lipid rafts due to its ceramide structural variation, which prevents endocytosis of the LTIIb-GD1a complex. The toxin receptors' ganglioside structures were evaluated as a moderator of this function, including ceramide chain length, level of saturation and hydroxylation, as well as glycan composition. To analyze these molecules, our previously developed method of direct coupling of TLC plates with VC-MALDI-FTMS was used. This allows direct TLC-MALDI-FTMS without adversely affecting the FT high resolution and mass accuracy by the surface irregularity of the TLC plate. Our earlier reports have described ganglioside purification from polarized intestinal epithelial cell line T-84 and monkey kidney Vero cells and functional studies on the mechanism of toxin biology. The samples were MALDI-desorbed directly off TLC plate surfaces with ~0.2 mm sampling steps. Fragmentation was subsequently performed by SORI-CAD and IRMPD. Both sialylated and highly fucosylated glycosphingolipids were observed. GC/MS analysis of released lipids and glycans were consistent with these observations. In recent experiments, GM1 has been modified with a fluorescent label and its traffic within the cells has been followed. Lencer's group has now determined that only GM1 with unsaturated acyl chains sorts efficiently from PM to the ER. Toxin binding was required, but other membrane components were also required, including cholesterol and the lipid raft protein flotillin. In the BUSM Mass Spectrometry Resource, the difference based on N-acyl fatty acid chains, degree of saturations, etc. of GM1 or fluorescent labeled GM1 is being investigated by high performance liquid chromatography coupled to an electrospray ionization (ESI) QStar Pulsar i time-of-flight (TOF) MS which combines, speed, sensitivity, high mass accuracy and high resolution. MALDI and ESI MS are also being used to verify that the fluorescent label is stable under the cellular conditions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of action for the IBD-risk gene INAVA: an epithelial guard receptor for inflammation and integrity of the intestinal barrier
-
批准号:10214604
-
项目类别:
-
资助金额:$51.69万
-
财政年份:2020
-
负责人:WAYNE I LENCER
-
依托单位:
Mechanisms of action for the IBD-risk gene INAVA: an epithelial guard receptor for inflammation and integrity of the intestinal barrier
-
批准号:10626015
-
项目类别:
-
资助金额:$49.24万
-
财政年份:2020
-
负责人:WAYNE I LENCER
-
依托单位:
Mechanisms of action for the IBD-risk gene INAVA: an epithelial guard receptor for inflammation and integrity of the intestinal barrier
-
批准号:10405643
-
项目类别:
-
资助金额:$49.24万
-
财政年份:2020
-
负责人:WAYNE I LENCER
-
依托单位:
Intestinal Disease-enterocyte toxin interaction
-
批准号:9263933
-
项目类别:
-
资助金额:$71.69万
-
财政年份:2016
-
负责人:WAYNE I LENCER
-
依托单位:
Intestinal Disease-enterocyte toxin interaction
-
批准号:9167689
-
项目类别:
-
资助金额:$74.19万
-
财政年份:2016
-
负责人:WAYNE I LENCER
-
依托单位:
Intestinal Disease-enterocyte toxin interaction
-
批准号:9899224
-
项目类别:
-
资助金额:$71.69万
-
财政年份:2016
-
负责人:WAYNE I LENCER
-
依托单位:
Unsaturated glycoceramide as novel platform for mucosal vaccine and drug delivery
-
批准号:8145606
-
项目类别:
-
资助金额:$21.51万
-
财政年份:2010
-
负责人:WAYNE I LENCER
-
依托单位:
STRUCTURAL CHARACTERIZATION OF TOXIN-BINDING GANGLIOSIDES BY TLC/VC-FTMS
-
批准号:8170895
-
项目类别:
-
资助金额:$0.46万
-
财政年份:2010
-
负责人:WAYNE I LENCER
-
依托单位:
Unsaturated glycoceramide as novel platform for mucosal vaccine and drug delivery
-
批准号:8030610
-
项目类别:
-
资助金额:$25.79万
-
财政年份:2010
-
负责人:WAYNE I LENCER
-
依托单位:
FcRn-dependent sorting of IgG and IgG-opsinized antigens by epithelial cells
-
批准号:8538945
-
项目类别:
-
资助金额:$35.79万
-
财政年份:2009
-
负责人:WAYNE I LENCER
-
依托单位:
FcRn-dependent sorting of IgG and IgG-opsinized antigens by epithelial cells
-
批准号:7903438
-
项目类别:
-
资助金额:$40.85万
-
财政年份:2009
-
负责人:WAYNE I LENCER
-
依托单位:
FASEB Summer Research Conference 2009
-
批准号:7614152
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2009
-
负责人:WAYNE I LENCER
-
依托单位:
FcRn-dependent sorting of IgG and IgG-opsinized antigens by epithelial cells
-
批准号:8133845
-
项目类别:
-
资助金额:$37.06万
-
财政年份:2009
-
负责人:WAYNE I LENCER
-
依托单位:
FcRn-dependent sorting of IgG and IgG-opsinized antigens by epithelial cells
-
批准号:7713651
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2009
-
负责人:WAYNE I LENCER
-
依托单位:
STRUCTURAL CHARACTERIZATION OF TOXIN-BINDING GANGLIOSIDES BY TLC/VC-FTMS
-
批准号:7955924
-
项目类别:
-
资助金额:$0.47万
-
财政年份:2009
-
负责人:WAYNE I LENCER
-
依托单位:
FcRn-dependent sorting of IgG and IgG-opsinized antigens by epithelial cells
-
批准号:8322163
-
项目类别:
-
资助金额:$37.09万
-
财政年份:2009
-
负责人:WAYNE I LENCER
-
依托单位:
STRUCTURAL CHARACTERIZATION OF TOXIN-BINDING GANGLIOSIDES BY TLC/VC-FTMS
-
批准号:7723017
-
项目类别:
-
资助金额:$3.89万
-
财政年份:2008
-
负责人:WAYNE I LENCER
-
依托单位:
STRUCTURAL CHARACTERIZATION OF TOXIN-BINDING GANGLIOSIDES BY TLC/VC-FTMS
-
批准号:7602011
-
项目类别:
-
资助金额:$6.46万
-
财政年份:2007
-
负责人:WAYNE I LENCER
-
依托单位:
STRUCTURAL CHARACTERIZATION OF TOXIN-BINDING GANGLIOSIDES BY TLC/VC-FTMS
-
批准号:7369281
-
项目类别:
-
资助金额:$4.52万
-
财政年份:2006
-
负责人:WAYNE I LENCER
-
依托单位:
Administrative Core
-
批准号:7499778
-
项目类别:
-
资助金额:$71.11万
-
财政年份:2006
-
负责人:WAYNE I LENCER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: